BioCryst Pharma (BCRX) Receives BARDA Contract to Continue BCX4430 Development
Tweet Send to a Friend
BioCryst Pharma (NASDAQ: BCRX) announced that the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE